0001104659-21-109182.txt : 20210825
0001104659-21-109182.hdr.sgml : 20210825
20210825081528
ACCESSION NUMBER: 0001104659-21-109182
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210823
FILED AS OF DATE: 20210825
DATE AS OF CHANGE: 20210825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenspan Ira Scott
CENTRAL INDEX KEY: 0001449211
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39788
FILM NUMBER: 211203760
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Scopus BioPharma Inc.
CENTRAL INDEX KEY: 0001772028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821248020
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
BUSINESS PHONE: (212) 479-2513
MAIL ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
FORMER COMPANY:
FORMER CONFORMED NAME: Scopus Biopharma Inc.
DATE OF NAME CHANGE: 20190327
4
1
tm2125834-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-08-23
0
0001772028
Scopus BioPharma Inc.
SCPS
0001449211
Greenspan Ira Scott
C/O SCOPUS BIOPHARMA INC.
420 LEXINGTON AVENUE, SUITE 300
NEW YORK
NY
10170
1
1
1
0
Executive Committee Chairman
Common Stock, par value $0.001
2021-08-23
4
P
0
500
4.41
A
82290
D
Common Stock, par value $0.001
2021-08-24
4
P
0
50
4.65
A
82340
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.38 to $4.45 per share inclusive. The Reporting
Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.50 to $4.70 per share inclusive. The Reporting
Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.
/s/ Ira Scott Greenspan
2021-08-25